https://www.cancertherapyadvisor.com/home/news/conference-coverage/suo-2023/genomic-clinicopathologic-risk-groups-prognostication-prostate-cancer/
Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.
Create an account or login to join the discussion